HIV-1 Genomes Are Enriched in Memory CD4


Journal

mBio
ISSN: 2150-7511
Titre abrégé: mBio
Pays: United States
ID NLM: 101519231

Informations de publication

Date de publication:
26 10 2021
Historique:
pubmed: 22 9 2021
medline: 28 1 2022
entrez: 21 9 2021
Statut: ppublish

Résumé

Future HIV-1 curative therapies require a thorough understanding of the distribution of genetically-intact HIV-1 within T-cell subsets during antiretroviral therapy (ART) and the cellular mechanisms that maintain this reservoir. Therefore, we sequenced near-full-length HIV-1 genomes and identified genetically-intact and genetically-defective genomes from resting naive, stem-cell memory, central memory, transitional memory, effector memory, and terminally-differentiated CD4

Identifiants

pubmed: 34544282
doi: 10.1128/mBio.02447-21
pmc: PMC8546577
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0244721

Subventions

Organisme : NIAID NIH HHS
ID : K24 AI145806
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI116368
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI096109
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI126611
Pays : United States

Références

Sci Rep. 2016 Nov 14;6:37021
pubmed: 27841315
PLoS Pathog. 2021 Jan 19;17(1):e1009214
pubmed: 33465157
J Virol. 1993 Nov;67(11):6365-78
pubmed: 8411338
JCI Insight. 2021 Feb 8;6(3):
pubmed: 33400687
Nat Med. 2009 Aug;15(8):955-9
pubmed: 19597505
Proc Natl Acad Sci U S A. 2013 Dec 17;110(51):E4987-96
pubmed: 24277811
J Infect Dis. 2019 Mar 15;219(7):1084-1094
pubmed: 30371873
Science. 1997 Nov 14;278(5341):1295-300
pubmed: 9360927
Sci Adv. 2019 Sep 25;5(9):eaav2045
pubmed: 31579817
Curr Opin Immunol. 2005 Jun;17(3):326-32
pubmed: 15886125
J Infect Dis. 2020 Jul 23;222(4):655-660
pubmed: 32236405
AIDS. 2020 Apr 1;34(5):659-668
pubmed: 31913161
Curr Opin HIV AIDS. 2019 Mar;14(2):108-114
pubmed: 30531293
Nat Med. 2018 Jul;24(7):923-926
pubmed: 29892063
Science. 1988 Nov 25;242(4882):1168-71
pubmed: 2460924
Cell. 2015 Jan 29;160(3):420-32
pubmed: 25635456
J Clin Invest. 2017 Jun 30;127(7):2689-2696
pubmed: 28628034
Virol J. 2020 Jan 7;17(1):4
pubmed: 31910871
Nat Med. 2016 Sep;22(9):1043-9
pubmed: 27500724
Cell Rep. 2017 Oct 17;21(3):813-822
pubmed: 29045846
J Infect Dis. 2015 Aug 15;212(4):596-607
pubmed: 25712966
Cytometry B Clin Cytom. 2017 Jan;92(1):21-32
pubmed: 27997758
Nature. 2002 May 2;417(6884):95-8
pubmed: 11986671
Nature. 1999 Oct 14;401(6754):708-12
pubmed: 10537110
PLoS One. 2012;7(3):e33948
pubmed: 22479485
Nat Med. 2014 Feb;20(2):139-42
pubmed: 24412925
Nat Commun. 2017 Nov 13;8(1):1473
pubmed: 29133794
Nat Commun. 2019 Feb 13;10(1):728
pubmed: 30760706
J Virol. 2014 Sep 1;88(17):10056-65
pubmed: 24965451
Oncotarget. 2017 Apr 18;8(16):27569-27581
pubmed: 28187438
Cell. 2002 Dec 13;111(6):853-66
pubmed: 12526811
Adv Pharmacol. 2007;55:389-409
pubmed: 17586321
Proc Natl Acad Sci U S A. 2016 Feb 16;113(7):1883-8
pubmed: 26858442
Nat Med. 2009 Aug;15(8):893-900
pubmed: 19543283
Cytometry A. 2008 Nov;73(11):975-83
pubmed: 18785267
Biom J. 2008 Jun;50(3):346-63
pubmed: 18481363
Nat Med. 2003 Jun;9(6):727-8
pubmed: 12754504
Nucleic Acids Res. 2019 Jul 2;47(W1):W256-W259
pubmed: 30931475
J Clin Invest. 2006 Jun;116(6):1514-24
pubmed: 16691294
Nature. 1997 May 8;387(6629):183-8
pubmed: 9144289
Cell Host Microbe. 2019 Sep 11;26(3):347-358.e7
pubmed: 31471273
Immunity. 2014 Dec 18;41(6):886-97
pubmed: 25526304
Nat Protoc. 2007;2(12):3045-57
pubmed: 18079703
J Clin Invest. 2021 Feb 1;131(3):
pubmed: 33301425
J Virol. 2020 Jan 17;94(3):
pubmed: 31723024
PLoS Pathog. 2017 Mar 22;13(3):e1006283
pubmed: 28328934
J Virol. 2015 Nov 18;90(3):1369-76
pubmed: 26581989
Science. 2014 Jul 11;345(6193):179-83
pubmed: 24968937
J Exp Med. 2004 Jul 19;200(2):255-60
pubmed: 15249595
AIDS. 2010 Nov 27;24(18):2803-8
pubmed: 20962613
J Exp Med. 2020 Jul 6;217(7):
pubmed: 32311008
PLoS Med. 2017 Nov 7;14(11):e1002417
pubmed: 29112956
Blood. 2010 Oct 28;116(17):3238-48
pubmed: 20631381
Science. 2014 Aug 1;345(6196):570-3
pubmed: 25011556
J Virol. 2013 Feb;87(3):1770-8
pubmed: 23175380
PLoS Pathog. 2007 Apr;3(4):e58
pubmed: 17465678
Mol Biol Evol. 2009 Jul;26(7):1641-50
pubmed: 19377059
Proc Natl Acad Sci U S A. 2012 Jun 12;109(24):9523-8
pubmed: 22645358
Curr Protoc Immunol. 2005 Mar;Chapter 12:Unit 12.12
pubmed: 18432939
Nat Med. 2011 Oct 11;17(10):1182-3
pubmed: 21988989

Auteurs

Vincent Morcilla (V)

Centre for Virus Research, The Westmead Institute for Medical Research, The University of Sydney, Sydney, New South Wales, Australia.

Charline Bacchus-Souffan (C)

Division of Experimental Medicine, Department of Medicine, University of California San Francisco, San Francisco, California, USA.

Katie Fisher (K)

Centre for Virus Research, The Westmead Institute for Medical Research, The University of Sydney, Sydney, New South Wales, Australia.
Sydney Medical School, Westmead Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.

Bethany A Horsburgh (BA)

Centre for Virus Research, The Westmead Institute for Medical Research, The University of Sydney, Sydney, New South Wales, Australia.
Sydney Medical School, Westmead Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.

Bonnie Hiener (B)

Centre for Virus Research, The Westmead Institute for Medical Research, The University of Sydney, Sydney, New South Wales, Australia.
Sydney Medical School, Westmead Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.

Xiao Qian Wang (XQ)

Centre for Virus Research, The Westmead Institute for Medical Research, The University of Sydney, Sydney, New South Wales, Australia.
Sydney Medical School, Westmead Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.

Timothy E Schlub (TE)

Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.

Mark Fitch (M)

Department of Nutritional Sciences and Toxicology, University of California Berkeley, Berkeley, California, USA.

Rebecca Hoh (R)

Division of HIV, Infectious Diseases and Global Medicine, Department of Medicine, Zuckerberg San Francisco General Hospital, University of California San Francisco, San Francisco, California, USA.

Frederick M Hecht (FM)

Division of HIV, Infectious Diseases and Global Medicine, Department of Medicine, Zuckerberg San Francisco General Hospital, University of California San Francisco, San Francisco, California, USA.

Jeffrey N Martin (JN)

Division of HIV, Infectious Diseases and Global Medicine, Department of Medicine, Zuckerberg San Francisco General Hospital, University of California San Francisco, San Francisco, California, USA.

Steven G Deeks (SG)

Division of HIV, Infectious Diseases and Global Medicine, Department of Medicine, Zuckerberg San Francisco General Hospital, University of California San Francisco, San Francisco, California, USA.

Marc K Hellerstein (MK)

Department of Nutritional Sciences and Toxicology, University of California Berkeley, Berkeley, California, USA.

Joseph M McCune (JM)

Global Health Innovative Technology Solutions/HIV Frontiers, Bill & Melinda Gates Foundation, Seattle, Washington, USA.

Peter W Hunt (PW)

Division of Experimental Medicine, Department of Medicine, University of California San Francisco, San Francisco, California, USA.

Sarah Palmer (S)

Centre for Virus Research, The Westmead Institute for Medical Research, The University of Sydney, Sydney, New South Wales, Australia.
Sydney Medical School, Westmead Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH